Polaryx Therapeutics, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Polaryx Therapeutics, Inc. (PLYX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 4.19 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- Polaryx Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 4.19M shares, a 38.66% increase year-over-year.
- Polaryx Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 4.19M shares, a 38.66% increase year-over-year.
- Polaryx Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 3.02M shares.
- Polaryx Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 3.02M shares.
- Polaryx Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 4.58M shares, a 53.71% increase from fiscal 2024.
- Polaryx Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 2.98M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|
| 2026-06-30 | 4.19M shares 10-Q · filed 2026-08-13 | 4.19M shares 10-Q · filed 2026-08-13 | |
| 2026-03-31 | 4.19M shares 10-Q · filed 2026-05-15 | ||
| 2025-12-31 | 4.58M shares 10-K · filed 2026-03-24 | ||
| 2025-06-30 | 3.02M shares 10-Q · filed 2026-08-13 | 3.02M shares 10-Q · filed 2026-08-13 | |
| 2025-03-31 | 3.02M shares 10-Q · filed 2026-05-15 | ||
| 2024-12-31 | 2.98M shares 10-K · filed 2026-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |